Mesoblast (MESO) Operating Income: 2015-2023
Historic Operating Income for Mesoblast (MESO) over the last 7 years, with Jun 2023 value amounting to -$43.4 million.
- Mesoblast's Operating Income rose 28.99% to -$43.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$10.3 million, marking a year-over-year increase of 53.45%. This contributed to the annual value of -$62.0 million for FY2025, which is N/A change from last year.
- According to the latest figures from Q2 2023, Mesoblast's Operating Income is -$43.4 million, which was down 481.57% from $11.4 million recorded in Q1 2023.
- Over the past 5 years, Mesoblast's Operating Income peaked at $33.5 million during Q3 2019, and registered a low of -$97.3 million during Q2 2021.
- Its 3-year average for Operating Income is -$11.6 million, with a median of $11.3 million in 2022.
- The largest annual percentage gain for Mesoblast's Operating Income in the last 5 years was 118.94% (2021), contrasted with its biggest fall of 3,928.91% (2021).
- Mesoblast's Operating Income (Quarterly) stood at $18.0 million in 2019, then decreased by 6.61% to $16.8 million in 2020, then fell by 16.44% to $14.0 million in 2021, then dropped by 25.32% to $10.5 million in 2022, then grew by 28.99% to -$43.4 million in 2023.
- Its Operating Income was -$43.4 million in Q2 2023, compared to $11.4 million in Q1 2023 and $10.5 million in Q4 2022.